Publications by authors named "Josep M Grau"

This study aimed to assess acute and residual changes in sprint-related hamstring injury (HSI) risk factors after a football (soccer) match, focusing on recovery within the commonly observed 72-h timeframe between elite football matches. We used a multifactorial approach within a football context, incorporating optical and ultrastructural microscopic analysis of BFlh (biceps femoris long head) muscle fibres, along with an examination of BFlh fibre composition. Changes in sprint performance-related factors and HSI modifiable risk factors were examined until 3 days after the match (MD ) in 20 football players.

View Article and Find Full Text PDF

Objectives: Autoantibodies targeting intracellular proteins are common in various autoimmune diseases. In the context of myositis, the pathologic significance of these autoantibodies has been questioned due to the assumption that autoantibodies cannot enter living muscle cells. This study aims to investigate the validity of this assumption.

View Article and Find Full Text PDF

Background: Microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) are the two major antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Objectives: To characterize a homogenous AAV cohort and to assess the impact of clinicopathological profiles and ANCA serotypes on clinical presentation and prognosis. Clinical differences in GPA patients according to ANCA serotype and the diagnostic yield for vasculitis of biopsies in different territories were also investigated.

View Article and Find Full Text PDF
Article Synopsis
  • Myositis is an autoimmune muscle disease characterized by autoantibodies that target proteins within muscle cells, but their impact on disease development was previously unclear.* -
  • This study utilized confocal microscopy and bulk RNA sequencing on muscle biopsies to investigate the presence and effects of these autoantibodies, revealing they accumulate in muscle fibers and disrupt the normal function of their target proteins.* -
  • Findings showed that the internalization of these autoantibodies led to significant changes in gene expression and function, indicating that they play a crucial role in causing the pathology associated with myositis.*
View Article and Find Full Text PDF

Pompe disease is a rare genetic disorder with an estimated prevalence of 1:60.000. The two main phenotypes are Infantile Onset Pompe Disease (IOPD) and Late Onset Pompe Disease (LOPD).

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICI) improve cancer treatment but can trigger immune-related conditions, including dermatomyositis (DM).
  • This study analyzed three DM cases linked to ICI from a patient cohort and reviewed existing literature on the topic.
  • All cases were associated with specific ICI drugs and showed a strong presence of anti-TIF1γ autoantibodies, suggesting these antibodies may contribute to developing DM in some patients.
View Article and Find Full Text PDF

Complement proteins are deposited in the muscles of patients with myositis. However, the local expression and regulation of complement genes within myositis muscle have not been well characterized. In this study, bulk RNA sequencing (RNAseq) analyses of muscle biopsy specimens revealed that complement genes are locally overexpressed and correlate with markers of myositis disease activity, including the expression of interferon-gamma (IFNγ)-induced genes.

View Article and Find Full Text PDF

Dermatomyositis is a systemic vasculopathy mainly affecting skin, muscle and lung, but may affect the gastrointestinal tract. We aim to describe clinical characteristics of patients with severe gastrointestinal involvement related to dermatomyositis in our center and medical literature. We retrospectively analysed these patients in our center, including cases of erosions/ulcers, perforation or digestive bleeding.

View Article and Find Full Text PDF

Background: Ganciclovir/valganciclovir is currently indicated during the first 6 months of life in symptomatic children with congenital cytomegalovirus (CMV) infection. However, this treatment may have the potential to induce mitochondrial toxicity due to off-target inhibition of DNA-polymerases. Similar anti-HIV drugs have been associated with mitochondrial toxicity but this has never been explored in CMV.

View Article and Find Full Text PDF

Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene () were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA).

View Article and Find Full Text PDF

Idiopathic Parkinson's disease (iPD) and type 2 diabetes mellitus (T2DM) are chronic, multisystemic, and degenerative diseases associated with aging, with eventual epidemiological co-morbidity and overlap in molecular basis. This study aims to explore if metabolic and mitochondrial alterations underlie the previously reported epidemiologic and clinical co-morbidity from a molecular level. To evaluate the adaptation of iPD to a simulated pre-diabetogenic state, we exposed primary cultured fibroblasts from iPD patients and controls to standard (5 mM) and high (25 mM) glucose concentrations to further characterize metabolic and mitochondrial resilience.

View Article and Find Full Text PDF

Objectives: The subsarcolemmal accumulation of p62 aggregates in myofibres has been proposed to be characteristic of sporadic inclusion body myositis (sIBM). The objective of this study was to analyse the patterns and prevalence of p62 immunostaining and to quantitate p62 gene expression in muscle biopsies from a large number of patients with different types of myopathic and neurogenic disorders.

Methods: For the p62 immunostaining analysis, all patients with a muscle biopsy immunostained for p62 at the Johns Hopkins Neuromuscular Pathology Laboratory from 2013 to 2017 were included (n=303).

View Article and Find Full Text PDF

Objectives: Statins are the cornerstone of the treatment and prevention of cardiovascular disease but have been associated with muscular side effects, among others. If patients are not properly evaluated, statin discontinuation may take place, leaving patients' symptoms unresolved and precluding an effective cardiovascular treatment. The present study aims to describe the clinical characteristics, the diagnostic process and the final diagnosis of selected patients with suspected statin-induced myopathy, with quite different alternative diagnoses.

View Article and Find Full Text PDF
Article Synopsis
  • Anoctamin 5 (ANO5) is linked to a range of muscle issues, from mild symptoms to serious weaknesses, due to genetic mutations.
  • A study analyzed 1700 muscle biopsies over several years, focusing on cases like those involving ANO5 to understand the conditions better.
  • Three patients with different muscle problems were identified, all sharing a common genetic mutation, highlighting the disease's complexity and varied symptoms, as well as unique patterns seen in muscle biopsies.
View Article and Find Full Text PDF

Background And Objective: Drug-induced myopathy is among the most common causes of muscle disease. An association has recently been described between programmed death-1 (PD-1)/PD-1 ligand (PD-L1) inhibitors and immune-related adverse events (irAE) affecting the muscle. Here, we report the clinical and pathological findings of nine unrelated patients with PD-1 and PD-L1 inhibitors-associated myopathy.

View Article and Find Full Text PDF
Article Synopsis
  • Late onset Pompe disease (LOPD) leads to gradual weakness in skeletal and respiratory muscles, which is treated with enzyme replacement therapy (ERT) using alglucosidase alpha (rhGAA).
  • In a study of 25 ERT-treated patients, 72% developed antibodies against rhGAA, but their impact on clinical progression was examined with muscle function tests, spirometry, and quantitative MRI over one year.
  • Results showed that low and intermediate antibody levels did not significantly affect muscle function, breathing tests, or MRI outcomes, suggesting these antibodies may not hinder the effectiveness of the treatment.
View Article and Find Full Text PDF

Background And Objectives: Sporadic inclusion body myositis (sIBM) diagnosis is frequently delayed or confused with another class of disorders, and misdiagnosis is common. Sometimes, we have problems diagnosing an sIBM in the early stages or predicting when a PM is going to become an sIBM. In this sense, we believe that p62 immunostaining could help clinicians.

View Article and Find Full Text PDF

PRKN encodes an E3-ubiquitin-ligase involved in multiple cell processes including mitochondrial homeostasis and autophagy. Previous studies reported alterations of mitochondrial function in fibroblasts from patients with PRKN mutation-associated Parkinson's disease (PRKN-PD) but have been only conducted in glycolytic conditions, potentially masking mitochondrial alterations. Additionally, autophagy flux studies in this cell model are missing.

View Article and Find Full Text PDF

Intrauterine growth restriction (IUGR) is an obstetric complication characterised by placental insufficiency and secondary cardiovascular remodelling that can lead to cardiomyopathy in adulthood. Despite its aetiology and potential therapeutics are poorly understood, bioenergetic deficits have been demonstrated in adverse foetal and cardiac development. We aimed to evaluate the role of mitochondria in human pregnancies with IUGR.

View Article and Find Full Text PDF

Introduction: Short tau inversion recovery (STIR) sequences in whole-body MRI are usually used for detecting muscle edema (ME) in inflammatory myopathies. We evaluated b-value 800 diffusion-weighted imaging (b800 DWI).

Methods: Two radiologists independently and a consensus reader retrospectively reexamined 60 patients with inflammatory myopathies and 15 controls.

View Article and Find Full Text PDF

Objectives: The aim of this study was to compare muscle biopsy findings, as well as clinical and analytical features, with those of magnetic resonance imaging (MRI) studies of muscle in patients with dermatomyositis.

Methods: All patients from the Longitudinal Myopathy Cohort of the Hospital Clínic de Barcelona were prospectively included in the study from 2009 to 2016. MRI images of muscle and fascial oedema were compared with muscle pathology results using both quantitative and semi-quantitative scores.

View Article and Find Full Text PDF

Background: Giant-cell arteritis (GCA) is considered a T helper (Th)1- and Th17-mediated disease. Interleukin (IL)-12 is a heterodimeric cytokine (p35/p40) involved in Th1 differentiation. When combining with p19 subunit, p40 compose IL-23, a powerful pro-inflammatory cytokine that maintains Th17 response.

View Article and Find Full Text PDF